Chapter 40 Antimuscarinic drugs in the treatment of movement disorders (Q61881981)

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Serum trihexyphenidyl levels in the treatment of torsion dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Tardive dystonia: Late-onset and persistent dystonia caused by antipsychotic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Validity and reliability of a rating scale for the primary torsion dystonias

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Torsion dystonia: a double-blind, prospective trial of high-dosage trihexyphenidyl

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Evaluating storage, retention, and retrieval in disordered memory and learning

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Bromocriptine in Parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Dystonic reactions in children caused by metoclopramide

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

A physiologic and pharmacologic study in anticholinergic-responsive essential myoclonus

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Trihexyphenidyl; evaluation of the new agent in the treatment of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Aromatic Amino Acids and Modification of Parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Antiparkinsonian drugs: inhibition of dopamine uptake in the corpus striatum as a possible mechanism of action

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Artane therapy for parkinsonism; a preliminary study of results in 117 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Human memory and the cholinergic system. A relationship to aging?

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

High dosage anticholinergic therapy in dystonia

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Tolcapone: COMT inhibition for the treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Regional distribution of choline acetylase in the brain of the rhesus monkey.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Improvement of ataxic hemiparesis with trihexyphenidyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Effectiveness of trihexyphenidyl against pendular nystagmus and palatal myoclonus: evidence of cholinergic dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Parkinsonism-plus syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Natural history and treatment of tardive dystonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Metoclopramide: a review of its pharmacological properties and clinical use

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Skeletal myoclonus in olivopontocerebellar atrophy: treatment with trihexyphenidyl

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Serum Levels of Anticholinergic Drugs in Treatment of Acute Extrapyramidal Side Effects

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021

Severe extrapyramidal motor activity induced by prochlorperazine. Its relief by the intravenous injection of diphenhydramine

1 reference

https://api.crossref.org/works/10.1016%2FS0079-6123%2808%2960922-X

7 January 2021